Kits (3)Antibody (1)
Launched (4)
AAV (3)Mouse (1)
- (4)
- (3)Unconjugated (1)
| Cat. No. | Species | Host | Product Description | Structure | Purity | Feature | Order Now |
|---|---|---|---|---|---|---|---|
AA2-Y2130 | Hybridoma | Monoclonal Anti-Adenoviruses AAV2 Antibody, Mouse IgG1 (23F8A5) | |||||
AAV-A002 | AAV | - | AAV2 Titration ELISA Kit | ||||
AAV-A002H | AAV | - | AAV2 Titration ELISA Kit (Fast) | ||||
PAV-A002 | AAV | - | Anti-AAV2 Antibody ELISA Kit |
| English Name | Research Code | Highest Development Stage | Company | Indication | Clinical Trial |
|---|---|---|---|---|---|
| MOG autologous T-lymphocyte cell therapy (ImCyse) | Phase 2 Clinical | Imcyse Sa | Multiple Sclerosis | Details |

[North America]: +1 800-810-0816
[Switzerland]: +41 800 040 012
[Asia & Pacific]: +86 400-682-2521
[North America]: 1 Innovation Way, Newark, DE 19711, USA
[Switzerland]: ACRObiosystems AG, c/o Zug Dammstrasse Centre AG, Dammstrasse 19, 6300 Zug Switzerland



